Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Hepatitis B Vaccine (Yeast) 10 μg in Neonates
CTR20150106Phase 4Active
- Sponsor
- Shenzhen Kangtai Biological Products
- Start
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine (recombinant) in hepatitis B (HBV), sponsored by Shenzhen Kangtai Biological Products. Started Apr 2015; status: active.
02
Drugs
hepatitis b vaccine (recombinant)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on CTR20150106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150106.